First Squawk
@FirstSquawk
Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics
Joined July 2015
251 Following 567.9K Followers
BAUSCH + LOMB SAYS THE COMBINED POTENTIAL PEAK SALES FOR BOTH THERAPIES EXCEED $2 BLN, WITH PHASE 2 RESULTS FOR THE BL1332 OCULAR PAIN THERAPY EXPECTED IN COMING MONTHS.
